期刊
ARCHIVES OF INTERNAL MEDICINE
卷 170, 期 15, 页码 1383-1389出版社
AMER MEDICAL ASSOC
DOI: 10.1001/archinternmed.2010.199
关键词
-
资金
- Sanofi-Aventis Spain
- Bayer Schering Pharma
- [FIS 08/0200]
- [SEPAR 2008]
Background: The Pulmonary Embolism Severity Index (PEST) estimates the risk of 30-day mortality in patients with acute pulmonary embolism (PE): We constructed a simplified version of the PESI. Methods: The study retrospectively developed a simplified PESI clinical prediction rule for estimating the risk of 30-day mortality in a derivation cohort of Spanish outpatients. Simplified and original PEST performances were compared in the derivation cohort. The simplified PEST underwent retrospective external validation in an independent multinational cohort (Registro Informatizado de la Enfermedad Tromboembolica [RIETE] cohort) of outpatients. Results: In the derivation data set, univariate logistic regression of the original 11 PEST variables led to the removal of variables that did not reach statistical significance and subsequently produced the simplified PESI that contained the variables of age, cancer, chronic cardiopulmonary disease, heart rate, systolic blood pressure, and oxyhemoglobin saturation levels. The prognostic accuracy of the original and simplified PESI scores did not differ (area under the curve, 0.75 [95% confidence interval (CI), 0.69-0.80]). The 305 of 995 patients (30.7%) who were classified as low risk by the simplified PESI had a 30-day mortality of 1.0% (95% CI, 0.0%-2.1%) compared with 10.9% (8.5%-13.2%) in the high-risk group. In the RIETE validation cohort, 2569 of 7106 patients (36.2%) who were classified as low risk by the simplified PESI had a 30-day mortality of 1.1% (95% CI, 0.7%-1.5%) compared with 8.9% (8.1%-9.8%) in the high-risk group. Conclusion: The simplified PESI has similar prognostic accuracy and clinical utility and greater ease of use compared with the original PESI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据